Association of Variants of Arginine Vasopressin and Arginine Vasopressin Receptor 1A With Severe Acetaminophen Liver Injury

Matthew Randesi, Orna Levran, Joel Correa da Rosa, Julia Hankins, Jody Rule, Mary Jeanne Kreek, William M. Lee*, Adrian Reuben, Robert J. Fontana, Timothy Davern, Brendan McGuire, R. Todd Stravitz, Valerie Durkalski, Iris Liou, Oren Fix, Michael Schilsky, Daniel Ganger, Raymond T. Chung, David Koch, K. Rajender Reddy & 1 others Lorenzo Rossaro

*Corresponding author for this work

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background & Aims Acetaminophen-related acute liver injury and liver failure (ALF) result from ingestion of supratherapeutic quantities of this analgesic, frequently in association with other forms of substance abuse including alcohol, opioids, and cocaine. Thus, overdosing represents a unique high-risk behavior associated with other forms of drug use disorder. Methods We examined a series of 21 single nucleotide polymorphisms (SNPs) in 9 genes related to impulsivity and/or stress responsivity that may modify response to stress. Study subjects were 229 white patients admitted to tertiary care liver centers for ALF that was determined to be due to acetaminophen toxicity after careful review of historical and biochemical data. Identification of relevant SNPs used Sanger sequencing, TaqMan, or custom microarray. Association tests were carried out to compare genotype frequencies between patients and healthy white controls. Results The mean age was 37 years, and 75.6% were female, with similar numbers classified as intentional overdose or unintentional (without suicidal intent, occurring for a period of several days, usually due to pain). There was concomitant alcohol abuse in 30%, opioid use in 33.6%, and use of other drugs of abuse in 30.6%. The genotype frequencies of 2 SNPs were found to be significantly different between the cases and controls, specifically SNP rs2282018 in the arginine vasopressin gene (AVP, odds ratio 1.64) and SNP rs11174811 in the AVP receptor 1A gene (AVPR1A, odds ratio 1.89), both of which have been previously linked to a drug use disorder diagnosis. Conclusions Patients who develop acetaminophen-related ALF have increased frequency of gene variants that may cause altered stress responsivity, which has been shown to be associated with other unrelated substance use disorders.

Original languageEnglish (US)
Pages (from-to)500-505
Number of pages6
JournalCMGH
Volume3
Issue number3
DOIs
StatePublished - May 1 2017

Fingerprint

Vasopressin Receptors
Single Nucleotide Polymorphism
Substance-Related Disorders
Liver Failure
Acetaminophen
Wounds and Injuries
Opioid Analgesics
Odds Ratio
Genotype
Genes
Impulsive Behavior
Arginine Vasopressin
Liver
Street Drugs
Risk-Taking
Cocaine
Tertiary Care Centers
Gene Frequency
Alcoholism
Analgesics

Keywords

  • Impulsivity
  • Overdose
  • Pituitary-Adrenal Axis
  • Stress Responsivity

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Randesi, M., Levran, O., Correa da Rosa, J., Hankins, J., Rule, J., Kreek, M. J., ... Rossaro, L. (2017). Association of Variants of Arginine Vasopressin and Arginine Vasopressin Receptor 1A With Severe Acetaminophen Liver Injury. CMGH, 3(3), 500-505. https://doi.org/10.1016/j.jcmgh.2017.01.008
Randesi, Matthew ; Levran, Orna ; Correa da Rosa, Joel ; Hankins, Julia ; Rule, Jody ; Kreek, Mary Jeanne ; Lee, William M. ; Reuben, Adrian ; Fontana, Robert J. ; Davern, Timothy ; McGuire, Brendan ; Stravitz, R. Todd ; Durkalski, Valerie ; Liou, Iris ; Fix, Oren ; Schilsky, Michael ; Ganger, Daniel ; Chung, Raymond T. ; Koch, David ; Reddy, K. Rajender ; Rossaro, Lorenzo. / Association of Variants of Arginine Vasopressin and Arginine Vasopressin Receptor 1A With Severe Acetaminophen Liver Injury. In: CMGH. 2017 ; Vol. 3, No. 3. pp. 500-505.
@article{cc91efbb0fb94316ade5724f46f4140d,
title = "Association of Variants of Arginine Vasopressin and Arginine Vasopressin Receptor 1A With Severe Acetaminophen Liver Injury",
abstract = "Background & Aims Acetaminophen-related acute liver injury and liver failure (ALF) result from ingestion of supratherapeutic quantities of this analgesic, frequently in association with other forms of substance abuse including alcohol, opioids, and cocaine. Thus, overdosing represents a unique high-risk behavior associated with other forms of drug use disorder. Methods We examined a series of 21 single nucleotide polymorphisms (SNPs) in 9 genes related to impulsivity and/or stress responsivity that may modify response to stress. Study subjects were 229 white patients admitted to tertiary care liver centers for ALF that was determined to be due to acetaminophen toxicity after careful review of historical and biochemical data. Identification of relevant SNPs used Sanger sequencing, TaqMan, or custom microarray. Association tests were carried out to compare genotype frequencies between patients and healthy white controls. Results The mean age was 37 years, and 75.6{\%} were female, with similar numbers classified as intentional overdose or unintentional (without suicidal intent, occurring for a period of several days, usually due to pain). There was concomitant alcohol abuse in 30{\%}, opioid use in 33.6{\%}, and use of other drugs of abuse in 30.6{\%}. The genotype frequencies of 2 SNPs were found to be significantly different between the cases and controls, specifically SNP rs2282018 in the arginine vasopressin gene (AVP, odds ratio 1.64) and SNP rs11174811 in the AVP receptor 1A gene (AVPR1A, odds ratio 1.89), both of which have been previously linked to a drug use disorder diagnosis. Conclusions Patients who develop acetaminophen-related ALF have increased frequency of gene variants that may cause altered stress responsivity, which has been shown to be associated with other unrelated substance use disorders.",
keywords = "Impulsivity, Overdose, Pituitary-Adrenal Axis, Stress Responsivity",
author = "Matthew Randesi and Orna Levran and {Correa da Rosa}, Joel and Julia Hankins and Jody Rule and Kreek, {Mary Jeanne} and Lee, {William M.} and Adrian Reuben and Fontana, {Robert J.} and Timothy Davern and Brendan McGuire and Stravitz, {R. Todd} and Valerie Durkalski and Iris Liou and Oren Fix and Michael Schilsky and Daniel Ganger and Chung, {Raymond T.} and David Koch and Reddy, {K. Rajender} and Lorenzo Rossaro",
year = "2017",
month = "5",
day = "1",
doi = "10.1016/j.jcmgh.2017.01.008",
language = "English (US)",
volume = "3",
pages = "500--505",
journal = "Cellular and Molecular Gastroenterology and Hepatology",
issn = "2352-345X",
publisher = "Elsevier Inc.",
number = "3",

}

Randesi, M, Levran, O, Correa da Rosa, J, Hankins, J, Rule, J, Kreek, MJ, Lee, WM, Reuben, A, Fontana, RJ, Davern, T, McGuire, B, Stravitz, RT, Durkalski, V, Liou, I, Fix, O, Schilsky, M, Ganger, D, Chung, RT, Koch, D, Reddy, KR & Rossaro, L 2017, 'Association of Variants of Arginine Vasopressin and Arginine Vasopressin Receptor 1A With Severe Acetaminophen Liver Injury', CMGH, vol. 3, no. 3, pp. 500-505. https://doi.org/10.1016/j.jcmgh.2017.01.008

Association of Variants of Arginine Vasopressin and Arginine Vasopressin Receptor 1A With Severe Acetaminophen Liver Injury. / Randesi, Matthew; Levran, Orna; Correa da Rosa, Joel; Hankins, Julia; Rule, Jody; Kreek, Mary Jeanne; Lee, William M.; Reuben, Adrian; Fontana, Robert J.; Davern, Timothy; McGuire, Brendan; Stravitz, R. Todd; Durkalski, Valerie; Liou, Iris; Fix, Oren; Schilsky, Michael; Ganger, Daniel; Chung, Raymond T.; Koch, David; Reddy, K. Rajender; Rossaro, Lorenzo.

In: CMGH, Vol. 3, No. 3, 01.05.2017, p. 500-505.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Association of Variants of Arginine Vasopressin and Arginine Vasopressin Receptor 1A With Severe Acetaminophen Liver Injury

AU - Randesi, Matthew

AU - Levran, Orna

AU - Correa da Rosa, Joel

AU - Hankins, Julia

AU - Rule, Jody

AU - Kreek, Mary Jeanne

AU - Lee, William M.

AU - Reuben, Adrian

AU - Fontana, Robert J.

AU - Davern, Timothy

AU - McGuire, Brendan

AU - Stravitz, R. Todd

AU - Durkalski, Valerie

AU - Liou, Iris

AU - Fix, Oren

AU - Schilsky, Michael

AU - Ganger, Daniel

AU - Chung, Raymond T.

AU - Koch, David

AU - Reddy, K. Rajender

AU - Rossaro, Lorenzo

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Background & Aims Acetaminophen-related acute liver injury and liver failure (ALF) result from ingestion of supratherapeutic quantities of this analgesic, frequently in association with other forms of substance abuse including alcohol, opioids, and cocaine. Thus, overdosing represents a unique high-risk behavior associated with other forms of drug use disorder. Methods We examined a series of 21 single nucleotide polymorphisms (SNPs) in 9 genes related to impulsivity and/or stress responsivity that may modify response to stress. Study subjects were 229 white patients admitted to tertiary care liver centers for ALF that was determined to be due to acetaminophen toxicity after careful review of historical and biochemical data. Identification of relevant SNPs used Sanger sequencing, TaqMan, or custom microarray. Association tests were carried out to compare genotype frequencies between patients and healthy white controls. Results The mean age was 37 years, and 75.6% were female, with similar numbers classified as intentional overdose or unintentional (without suicidal intent, occurring for a period of several days, usually due to pain). There was concomitant alcohol abuse in 30%, opioid use in 33.6%, and use of other drugs of abuse in 30.6%. The genotype frequencies of 2 SNPs were found to be significantly different between the cases and controls, specifically SNP rs2282018 in the arginine vasopressin gene (AVP, odds ratio 1.64) and SNP rs11174811 in the AVP receptor 1A gene (AVPR1A, odds ratio 1.89), both of which have been previously linked to a drug use disorder diagnosis. Conclusions Patients who develop acetaminophen-related ALF have increased frequency of gene variants that may cause altered stress responsivity, which has been shown to be associated with other unrelated substance use disorders.

AB - Background & Aims Acetaminophen-related acute liver injury and liver failure (ALF) result from ingestion of supratherapeutic quantities of this analgesic, frequently in association with other forms of substance abuse including alcohol, opioids, and cocaine. Thus, overdosing represents a unique high-risk behavior associated with other forms of drug use disorder. Methods We examined a series of 21 single nucleotide polymorphisms (SNPs) in 9 genes related to impulsivity and/or stress responsivity that may modify response to stress. Study subjects were 229 white patients admitted to tertiary care liver centers for ALF that was determined to be due to acetaminophen toxicity after careful review of historical and biochemical data. Identification of relevant SNPs used Sanger sequencing, TaqMan, or custom microarray. Association tests were carried out to compare genotype frequencies between patients and healthy white controls. Results The mean age was 37 years, and 75.6% were female, with similar numbers classified as intentional overdose or unintentional (without suicidal intent, occurring for a period of several days, usually due to pain). There was concomitant alcohol abuse in 30%, opioid use in 33.6%, and use of other drugs of abuse in 30.6%. The genotype frequencies of 2 SNPs were found to be significantly different between the cases and controls, specifically SNP rs2282018 in the arginine vasopressin gene (AVP, odds ratio 1.64) and SNP rs11174811 in the AVP receptor 1A gene (AVPR1A, odds ratio 1.89), both of which have been previously linked to a drug use disorder diagnosis. Conclusions Patients who develop acetaminophen-related ALF have increased frequency of gene variants that may cause altered stress responsivity, which has been shown to be associated with other unrelated substance use disorders.

KW - Impulsivity

KW - Overdose

KW - Pituitary-Adrenal Axis

KW - Stress Responsivity

UR - http://www.scopus.com/inward/record.url?scp=85018250021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018250021&partnerID=8YFLogxK

U2 - 10.1016/j.jcmgh.2017.01.008

DO - 10.1016/j.jcmgh.2017.01.008

M3 - Article

VL - 3

SP - 500

EP - 505

JO - Cellular and Molecular Gastroenterology and Hepatology

JF - Cellular and Molecular Gastroenterology and Hepatology

SN - 2352-345X

IS - 3

ER -